Discordance Seen in Self-Reported, Actual Comorbidities in Native American Adults
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, July 18, 2023 -- There is discordance between the prevalence of self-reported comorbidities and measured cardiometabolic risk factors among Native American adults, according to a study published online July 6 in PLOS Global Health.
Leslie C. Redmond, from the University of Alaska Anchorage, and colleagues used participant data from the Obesity Prevention and Evaluation of InterVention Effectiveness in Native Americans 2 study to assess prevalence of cardiometabolic risk factors: hypertension, heart disease, diabetes, and obesity. A total of 601 Native American adults aged 18 to 75 years living in rural reservation communities in the Midwest and Southwest United States were surveyed for individual and family history, and clinical measures were also recorded by trained research staff.
The researchers found that about 60 percent of respondents had a body mass index greater than 30 kg/m2. Eight in 10 participants had a waist-to-hip ratio and percent body fat classified as high risk, and nearly two-thirds (64 percent) had a high-risk blood pressure measurement. A large proportion of participants reported a family history of chronic disease and had measurements that indicated elevated risk; however, relatively few self-reported a diagnosis of any chronic disease.
"Future studies should explore the impacts of access to care, health literacy, and cultural competence on the reporting and diagnosis of cardiometabolic risk factors in these Native American medically underserved population communities," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver Disease
FRIDAY, June 7, 2024 -- For adults with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide 1 receptor agonists...
Overweight in Teens, Young Adults Tied to Cerebrovascular Disease in Women
THURSDAY, June 6, 2024 -- Being overweight in adolescence or early adulthood is associated with an increased risk for cerebrovascular disease among women, according to a study...
Prevalence of Cardiovascular Risk Factors, Diseases Set to Increase
THURSDAY, June 6, 2024 -- The prevalence of cardiovascular risk factors and diseases will increase through 2050, and the associated economic burden is also projected to increase...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.